1 This study examined the possibility that an S-nitrosothiol, rather than nitric oxide, functions as the non-adrenergic, non-cholinergic (NANC) inhibitory neurotransmitter in the bovine retractor penis (BRP) muscle. 2 Treatment of BRP muscle with either of two sulphydryl inactivating agents, diamide (1 mM) and N-ethylmaleimide (0.3 mM), inhibited NANC relaxation and this was prevented by pretreating tissues with L-cysteine (3 mM), L-glutathione (3 mM) or dithiothreitol (3 mM). Inhibition was not specific, however, since the inactivating agents also inhibited the relaxant actions of authentic nitric oxide (0.3 .M), glyceryl trinitrate (0.001 -1 IgM) and isoprenaline (0.01-1 ZIM).
Introduction
It is now well established that the L-arginine nitric oxide for the hypotension associated with septic shock (Gray et al., system (Moncada, 1992) mediates the phenomenon of 1991; Kilbourn & Griffith, 1992) . Largely on the basis of the endothelium-dependent relaxation of blood vessels first actions of analogues of L-arginine that block nitric oxide renorted by Furchgott & Zawadzki (1980) . This system is synthesis (Bowman et al., 1986; Moore et al., 1990 ; Gibson et also responsible for the cytostatic and cytotoxic actions of al., 1990), we and others have recently proposed that tlis macrophages (Hibbs et al., 1988; Granger et al., 1990) , and system can also account for the inhibitory non-adrenergic, non-cholinergic (NANC) transmission process in anococcygeus muscles of the rat and mouse and the retractor penis ' Author for correspondence.
muscle of the bull (Gillespie et al., 1989; Gibson et al., 1990;  Hobbs Martin et al., 1993) . Subsequently, this system was shown in a variety of species to mediate NANC relaxant responses in the gastrointestinal tract (Boeckxstaens et al., 1991) , the lung (Tucker et al., 1990; Li & Rand, 1991) , corpus cavernosus (Ignarro et al., 1990; Pickard et al., 1991) , and penile and cerebral arteries (Toda & Okamura, 1990; Liu et al., 1991) . Furthermore, the same pathway is known to be present in certain neurones of the central nervous system (Garthwaite et al., 1988; Bredt et al., 1990; 1992) , and may play a role in nociception (Moore et al., 1993) as well as in long-term potentiation and inhibition (Schuman & Madison, 1991; . Controversy still exists, however, concerning the precise nature of the mediator produced by the L-arginine: nitric oxide system in the vascular endothelium. For example, although some authors have reported that the level of nitric oxide, measured either by chemiluminescence (Palmer et al., 1987) or by oxidation of haemoglobin (Kelm & Schrader, 1988) , can account for the activity of endothelium-derived relaxing factor (EDRF), others have challenged this view . Indeed, Myers et al. (1990) have proposed that the stability and potency of EDRF more closely resembles that of S-nitrosocysteine than of nitric oxide. Doubt has also been cast on the assumption that the NANC transmitter in the anococcygeus and BRP is simply nitric oxide (Gillespie & Sheng, 1990; Gibson et al., 1992) . Specifically, generation of the superoxide anion by the xanthine: xanthine oxidase system or by drugs such as pyrogallol or hydroquinone destroys the activity of authentic nitric oxide and of EDRF either in cascade bioassay systems. or in arterial rings Moncada et al., 1986; Rubanyi & Vanhoutte, 1986 ), but does not inhibit NANC relaxation (Gillespie & Sheng, 1990; Gibson et al., 1992) . It is possible therefore that the NANC neurotransmitter in these tissues may be a superoxide anion-resistant, nitric oxidereleasing molecule rather than free nitric oxide. The aim of this study was to investigate the possibility that S-nitrosocysteine or a related S-nitrosothiol acts as the NANC neurotransmitter in the BRP muscle. This was attempted first, by examining the actions of two sulphydryl inactivating agents, diamide and N-ethylmaleimide (Minor et al., 1989; Siegle et al., 1993) , on NANC relaxation, and secondly, by comparing the properties of the NANC transmitter with those of authentic nitric oxide and those of the relaxants produced following the reaction of nitric oxide with L-cysteine and certain structural analogues.
Methods

Preparation of tissues and tension recording
The bioassay of relaxant activity was assessed either on strips of bovine retractor penis (BRP) muscle or rings of rabbit aorta. BRP muscles were obtained from a local abattoir; some tissues were used that day but others were stored at 4°C in Krebs solution for use the following day. Strips of muscle (2 x 10 mm) were cut and suspended for tension recording either on glass hooks, or within Ag-AgCl ring electrodes if the NANC nerves were to be stimulated. The preparation of rabbit aortic rings was essentially as described previously (Martin et al., 1985) . Briefly, male New Zealand rabbits were killed by a lethal injection of pentobarbitone and exsanguination. The aorta was removed, cleared of adhering fat and connective tissue and cut into 2.5 mm wide transverse rings using a razor blade slicing device. Endothelial cells were removed from all rings by gently rubbing the intimal surface with moist filter paper. Rings were suspended for tension recording on stainless steel hooks. Both the aortic rings and BRP muscle strips were suspended under 2 g resting tension in 20 ml organ chambers and bathed at 37°C in Krebs solution comprising (mM): NaCI 118, KCI 4.8, CaCl2 2.5, MgSO4 dioxide. Nitric oxide gas was passed through the same solutions directly into the cuvette containing the L-cysteine for saturated solutions (-3 mM) or measured volumes of nitric oxide gas were removed with a gas-tight syringe and injected into the L-cysteine solution to give concentrations of 0.1 or 1 mM. The tubing connecting the wash bottles was stainless steel since rubber or plastic tubing absorbed nitrogen dioxide and was permeable to oxygen and the gas-tight syringe was flushed several times with purified oxygen-free nitrogen. Fieser's solution was prepared by adding 60 g of potassium hydroxide, 6 g of sodium anthraquinone-p-sulphonate and 45 g of sodium dithionite to 300 ml of distilled water (Fieser & Fieser, 1967) .
In some experiments, nitrogen dioxide (1 mM) was reacted with L-cysteine (10 mM) by the same procedure detailed above for nitric oxide. Nitrogen dioxide was prepared either by mixing purified nitric oxide gas with an equal volume of oxygen (British Oxygen Company) in a gas-tight syringe or liquid nitrogen dioxide was made by heating anhydrous lead nitrate and condensing the evolved nitrogen dioxide gas in a glass coil cooled with dry ice (Moody, 1991) .
These solutions were taken for bioassay or spectrophotometric analysis on a Shimadzu UV 240 dual beam spectrophotometer. High performance liquid chromatography (h.p.l.c.) separation was performed using a pBondpac Radial-Pac C18 reverse-phase column (8 x 100 mm) with distilled, deionised water at pH 3 at a flow rate of 1.5 ml min' and detection was by absorbance at 254 nm. Solutions of oxyhaemoglobin were prepared as previously described (Martin et al., 1985) . Briefly, a 10 fold molar excess of the reducing agent, sodium dithionite, was added to aqueous solutions of commercial haemoglobin (1 mM) and this was followed by dialysis against 100 volumes of distilled water for 2 h at 4°C. The resulting solutions were stored in aliquots at -20°C for up to 14 days.
Results
Effects of diamide and N-ethylmaleimide
Treatment with either of two sulphydryl inactivating agents, diamide (1 mm, Figure 1 ) and N-ethylmaleimide (0.3 mM), inhibited NANC relaxation of strips of BRP muscle. The blockade induced by diamide was partially reversed by treatment with the sulphydryl agents, L-cysteine (3 mM), Lglutathione (3 mM) or dithiothreitol (3 mM), but that induced by N-ethylmaleimide was completely unaffected. Pretreatment with L-cysteine (3 mM), L-glutathione (3 mM) or dithiothreitol (3 mM) completely prevented inhibition of NANC relaxation by diamide or N-ethylmaleimide. The relaxant actions of authentic nitric oxide (0.3 gM), glyceryl trinitrate (0.001-1I M), and isoprenaline (0.01-1 M) were also inhibited by treatment with diamide (1 mM) or Nethylmaleimide (0.3 mM). In these experiments also, the inhibitory actions of diamide and N-ethylmaleimide were completely prevented by pretreatment with the three sulphydryl compounds. Once established, however, the inhibitory actions of diamide and N-ethylmaleimide were not reversed by the three sulphydryl compounds.
Effects of nitric oxide and L-cysteine
Nitric oxide (1-100 nM) in oxygen-free solution induced concentration-dependent, transient relaxation of phenylephrine-contracted rings of rabbit aorta and strips of BRP muscle (Figures 2 and 8 ). L-Cysteine (1.5 mM) had no effect by itself, but mixing nitric oxide with L-cysteine in nominally oxygen-free solution at pH 3 followed by purging with oxygen-free nitrogen to remove any free nitric oxide and neutralisation, giving final bath concentrations equivalent to 0.5ytM nitric oxide and 1.5 mM L-cysteine, produced more powerful and sustained relaxation than nitric oxide alone ( Figure 2 ). Clearly, either L-cysteine protected nitric oxide or the two substances combined to form a new compound and these possibilities were tested by h.p.l.c. analysis. L-Cysteine itself produced two peaks in the h.p.l.c., representing its oxidised and reduced forms, respectively ( Figure 3 ). After mixing L-cysteine (1O mM) with nitric oxide (50 SOM) a third peak appeared indicating formation of a new compound and bioassay revealed that this peak contained all of the relaxant activity.
Functional groups of L-cysteine reacting with nitric oxide L-Cysteine has three functional groups which could potentially react with nitric oxide namely, the sulphydryl, carboxyl and amino groups. A series of analogues (all at 15 mM) were used in which each of these groups was modified and the effect on the ability to form the new relaxant activity following reaction with nitric oxide (0.1 mM) examined. The results were clear cut: modification of the sulphydryl always abolished the ability to form the new relaxant activity whereas modification of either of the other two groups had no effect. endothelium-denuded rings of rabbit aorta, and L-cysteine (1.5 mM) by itself had no effect. Reacting nitric oxide with L-cysteine in nominally oxygen-free solution at pH 3, followed by purging with oxygen-free nitrogen to remove any free nitric oxide and neutralisation, giving final bath concentrations of 0.5 JM nitric oxide and 1.5 mM L-cysteine, produced more powerful and sustained relaxation than could be attributed to nitric oxide alone. This powerful relaxant activity was rapidly abolished upon addition of haemoglobin (Hb Figure 3 . Subsequently, more stringent precautions were taken to exclude oxygen by immersing a sealed cuvette containing NO (nM) Figure 4 A series of structural analogues (all at 15 mM) was used to determine the functional group of the L-cysteine molecule with which nitric oxide (NO) reacts. Reacting nitric oxide (0.1 mM) with Lcysteine (15 mM) under nominally oxygen-free conditions at pH 3 produced powerful relaxant activity as assessed on phenylephrine (PE, 0.3 mM)-contracted, endothelium-denuded rings of rabbit aorta. L-cysteamine, which lacks the carboxyl group, and N-acetyl-Lcysteine, which has a substituent at the amino group, were able to react with nitric oxide to produce relaxant activity. In contrast, S-methyl-L-cysteine, which has a substituent at the sulphydryl, and L-cystine, the disulphide, failed to react with nitric oxide to produce relaxant activity. L-Glutathione, which also contains a free sulphydryl group reacted with nitric oxide to produce relaxant activity. Final bath equivalents of the reactants are given. L-cysteine (10 mM) at pH 3 in distilled water in an Amicon chamber and purging with nitrogen which had been passed through Fieser's solution followed by bubbling with nitric oxide (-3 mM) for 10 min then purging to remove free nitric oxide. These solutions were clear and their relaxant activity was less ( Figure 6 ) than in the earlier experiments (Figure 2) . Exposure of these solutions to air did not affect their relaxant activity. If, however, these solutions were not purged to remove free nitric oxide, opening the cuvette to the air instantly resulted in the development of a pink colour and a 40 fold increase in relaxant activity ( Figure 6 ). As would be expected, spectral changes accompanied this change in colour and activity. Where strict precautions were taken to exclude air and free nitric oxide was removed by purging, the clear solution had two new absorption peaks at 218 and 335 nm and these did not change upon exposing the cuvette contents to the air (Figure 6 ). If, however, the nitric oxide was not removed by purging, opening the cuvette to the air increased these two peaks some 40 fold, the same increase as was seen in relaxant activity. At the same time a third, new absorption peak appeared at 543 nm corresponding to the pink colour of the solution. Other experiments showed that if nitric oxide was not purged but left in contact with L-cysteine in the sealed cuvette than absorbance at 218, 335 and 543 nm increased slowly over a period of hours suggesting a slow entry of oxygen. Furthermore, if the cuvette was opened to the air at any time, the absorbance at these wavelengths increased within seconds to values similar to those shown on Figure 6 .
Reactivity of nitric oxide compared with nitrogen dioxide
Since the presence of oxygen greatly increased the generation of relaxant activity, we examined whether or not nitrogen dioxide was the species which reacted with L-cysteine. When either nitric oxide or nitrogen dioxide at 0.1 mM was reacted with L-cysteine (1O mM) at pH 3, relaxant activity and the associated third peak in the h.p.l.c. was only generated with the former (Figure 7) . If, however, the concentration of the two gases was increased to 1 mM, relaxant activity and the associated third peak in the h.p.l.c. were also generated with nitrogen dioxide, but the magnitude of these was lower than for nitric oxide. The effectiveness of this higher concentration probably results from the production of some nitrous acid and therefore nitric oxide from the solution of nitrogen dioxide.
Effects of haemoglobin, methylene blue, N-methylhydroxylamine and NG-nitro-L-arginine
While the relaxant effect of the new compound was presumably due to nitric oxide acting on soluble guanylate cyclase it was possible that this did not need to be released Figure 6 Bubbling nitric oxide gas to saturation ( 3 mM) in solutions of L-cysteine (10 mM) in stringent oxygen-free conditions (02-free) followed by purging with oxygen-free nitrogen to remove free nitric oxide and neutralisation produced low relaxant activity as assessed on phenylephrine (PE, 0.3 pM)-contracted, endotheliumdenuded rings of rabbit aorta. These solutions were colourless but contained two small absorption peaks at 218 and 335 nm (continuous line). If, however, nitric oxide was bubbled to saturation in solutions of L-cysteine (10 mM) and the reaction chamber was opened to the air (02) before purging and neutralisation, the relaxant activity generated was greatly (-40 fold) increased. The absorption peaks at 218 and 335 nm (discontinuous line) increased by a proportionate degree and a new peak became visible at 543 nm which was responsible for the development of a pink colour. Figure 7 (a) Reacting nitric oxide (NO, 0.1 mM) with L-cysteine (10 mM) under stringent oxygen-free conditions at pH 3 led to the development of relaxant activity as assessed on phenylephrine (0.3 LM)-contracted strips of bovine retractor penis muscle, and h.p.l.c. analysis revealed the presence of three peaks, representing L-cystine, L-cysteine and a new substance that was entirely responsible for relaxant activity. Reacting nitrogen dioxide (NO2, 0.1 mM) under identical conditions failed to generate relaxant activity or the associated third peak in the h.p.l.c. (b) If the concentration of nitrogen dioxide (NO2) was increased to I mm, relaxant activity and the associated third peak in the h.p.l.c. were generated but the magnitude of these was lower than those generated by nitric oxide (NO) at 1 mM. Figure 2 ), methylene blue (1O Mm) and N-methylhydroxylamine (100 Mm) abolished the activity of the new relaxant formed from reacting nitric oxide with L-cysteine or L-glutathione but N0-nitro-L-arginine (30 Mm) had not effect.
Effects ofpyrogallol and hydroquinone
As previously reported (Gillespie & Sheng, 1990) , we found that treatment of strips of BRP with the superoxide aniongenerating drugs, pyrogallol (0.1 mM, Figure 8 ) or hydroquinone (0.1 mM, data not shown), abolished the relaxant actions of authentic nitric oxide (0.3 gM) but had no effect on that to NANC nerve stimulation (2 Hz, 20 pulses). The effect on nitric oxide was blocked by superoxide dismutase (100 u ml-'). Treatment with pyrogallol (0.1 mM) or hydroquinone (0.1 mM, data not shown) also abolished the activity of the new relaxant generated following reaction of nitric oxide (1 mM) with L-cysteine (10 mM) or L-glutathione (10 mM, data not shown), and this inhibition too was reversed by superoxide dismutase (100 u ml-'). Furthermore, superoxide dismutase (100 u ml-') potentiated the actions of the new relaxant but had no effect on relaxation to NANC nerve stimulation. Other experiments showed that if pyrogallol (0.1 mM) or hydroquinone (0.1 mM) was added to the stimulation (2 Hz, 20 pulses) of the NANC nerves and the product (NO-Cys) of reacting nitric oxide (1 mM) with L-cysteine (10 mM) all relaxed strips of bovine retractor penis muscle. Treatment with pyrogallol (0.1 mM) abolished the relaxant actions of nitric oxide and of NO-Cys but had no effect on those to NANC nerve stimulation. The inhibitory effects of pyrogallol were reversed following treatment with superoxide dismutase (SOD, 100 u ml'). Superoxide dismutase also potentiated the relaxant actions of NO-Cys but had no effect on those to NANC nerve stimulation.
reaction chamber containing nitric oxide and L-cysteine or L-glutathione rather than to the BRP, then relaxant activity was also destroyed.
Discussion
It is now widely accepted that the L-arginine: nitric oxide system mediates inhibitory NANC transmission in the BRP and the related anococcygeus muscles of the rat and mouse (Gillespie et al., 1989; Gibson et al., 1990; Martin et al., 1993) . The finding that superoxide aniongenerating drugs such as pyrogallol and hydroquinone inhibit the relaxant actions of authentic nitric oxide but not of NANC nerve stimulation in the BRP and mouse anococcygeus (Gillespie & Sheng, 1990; Gibson et al., 1992) , suggests that the neurotransmitter in these tissues may be a superoxide anion-resistant, nitric oxide-releasing molecule rather than free nitric oxide. Indeed, an analogous debate continues concerning the precise nature of EDRF which Myers et al. (1990) suggest most closely resembles Snitrosocysteine than nitric oxide. If a compound does exist which binds nitric oxide and acts as a delivery system between synthesis in the nerve endings or endothelium and action on guanylate cyclase in the effector cells it would ideally meet certain conditions. Specifically, it would bind nitric oxide securely enough to preclude non-specific interactions with proteins and other substances and prevent destruction by superoxide anion. Furthermore, the binding would be reversible so as to deliver nitric oxide to guanylate cyclase. Sulphydryl inactivating agents have previously been employed to investigate the involvement of S-nitrosothiols in the activity of EDRF, but with equivocal results (Minor et al., 1989; Siegle et al., 1993) . We examined the actions of two agents, diamide and N-ethylmaleimide, which respectively oxidise and alkylate sulphydryl groups (Kosower et al., 1969; Siegle et al., 1993) . Consistent with involvement of an Snitrosothiol, we found that both blocked NANC relaxation and this was prevented by pretreating the tissues with excess sulphydryl groups in the form of L-cysteine, L-glutathione or dithiothreitol. These three sulphydryl compounds were also effective in reversing the actions of diamide, presumably through reduction of the -S-S-bonds formed following its action. The actions of N-ethylmaleimide were not reversed, suggesting that blockade had not resulted from covalent inactivation of the sulphydryl groups of endogenous Lcysteine or L-glutathione. The most compelling evidence against the blockade having resulted from loss of the ability to form S-nitrosothiols was obtained when we found that relaxation to nitric oxide, glyceryl trinitrate and isoprenaline was also blocked. It was clear, therefore, that the sulphydryl inactivating agents were blocking the effector pathways for these diverse relaxants and that any additional action in preventing formation of S-nitrosothiols by the NANC nerves would be impossible to discern.
Our next approach was to examine the properties of Snitrosothiols. A number of methods are available for the synthesis of these compounds, including the reaction of Lcysteine and nitrogen dioxide in cold methanol (Myers et al., 1990) , acidification of sodium nitrite in the presence of Lcysteine and other sulphydryl compounds (Kowaluk & Fung, 1990; Gibson et al., 1992; Kerr et al., 1993) , and the reaction of nitric oxide with L-cysteine and other sulphydryl compounds under anaerobic conditions (Ignarro & Gruetter, 1980; Ignarro et al., 1981) . The S-nitrosothiols produced by each of these routes are powerful smooth muscle relaxants, normally pink in colour, and have a characteristic absorption peak at around 335 nm. There is, however, enormous variability in the reported half-lives of the nitrosothiols produced by these methods ranging from -30s (Myers et al., 1990 ) to 7-10 days (Ignarro & Gruetter, 1980) . We initially adopted the method of Ignarro & Gruetter (1980) since we wished to determine if nitric oxide itself rather than higher oxides of nitrogen could react with the -S-H moiety of Lcysteine. This method has, however, been criticised by Feelisch (1991) who reported that the presence of oxygen was a prerequisite for nitrosation to proceed, and our observations supported this. We found that if nitric oxide was bubbled to saturation in solutions of L-cysteine under rigorous oxygen-free conditions that small absorption peaks were present at 218 and 335 nm, but the solution remained colourless. While still sealed, the absorption peaks at 218 and 335 nm grew slowly with time, but if the solution was opened to the air, they rose roughly 40 fold within a few seconds to stable new values and the solution became pink in colour owing to a new absorbance peak developing at 543 nm. It was likely, therefore, that the presence of oxygen was vital for nitric oxide and L-cysteine to react generating absorption peaks at 218, 335 and 543 nm, and that the small slowly growing peaks at 218 and 335 nm even under our most rigorous oxygen-free conditions were due to the slow entry of trace amounts of oxygen. The development of relaxant activity, as assessed on the BRP and rabbit aorta, was also critically dependent upon the availability of oxygen. Under our rigorous oxygen-free conditions when nitric oxide was allowed to react with L-cysteine, and then unreacted nitric oxide was removed by purging, some relaxant activity was generated, but this increased in direct proportion (-40 fold) to the increases in absorption at 218 and 335 nm if the solution was exposed to the air before purging.
The requirement for oxygen in the development of relaxant activity and associated absorption peaks showed that nitric oxide itself was unable to react with L-cysteine and that a higher oxide of nitrogen was the reactive species. There is debate over the precise nature of this nitrosating species; some have suggested that it is N203 or N204 (Leak et al., 1990) , but others dispute this suggesting that it is an as yet uncharacterized oxide of nitrogen (Wink et al., 1993) . We also dismissed the possibility that it was nitrogen dioxide, since this gas generated less relaxant activity than nitric oxide following reaction with L-cysteine.
H.p.l.c. analysis confirmed that nitric oxide had indeed reacted with L-cysteine to form a novel compound: the C18 column used fractionated the mixture into three peaks, representing L-cystine (the disulphide), L-cysteine and a third, new peak that was entirely responsible for relaxant activity. Our experiments with a series of structural analogues provided strong evidence that the reaction of nitric oxide or higher oxide was with the sulphydryl group. All derivatives of L-cysteine or L-glutathione in which this group was intact, irrespective of what changes were made in the amino or carboxyl groups, produced powerful relaxants whereas all the compounds in which the sulphydryl was modified were ineffective. It is likely therefore that the relaxants produced were the respective S-nitrosothiols. We confirmed, however, that the smooth muscle relaxant action of the nitrosothiols was derived from the nitric oxide they released (Ignarro et al., 1981; Gibson et al., 1992) , by finding that haemoglobin, which binds and inactivates nitric oxide, and methylene blue and N-methylhydroxylamine, which inhibit soluble guanylate cyclase, blocked their activity.
Another striking finding was that the reaction of nitric oxide with L-cysteine was pH-dependent: little relaxant activity was generated at neutral pH, but as the pH was lowered, relaxant activity was increased until an optimum was reached at pH 1. This process is reminiscent of the 'acid-activation' of inhibitory factor extracted from BRP (Gillespie & Martin, 1980) . The inactive form of inhibitory factor contains inorganic nitrite and upon acidification generates nitric oxide which binds to a substance which stabilizes its activity (Martin et al., 1988) . It has recently been proposed that the acid-activated inhibitory factor is Snitrosocysteine or S-nitrosoglutathione (Yui et al., 1989; Kerr et al., 1993) . Although it is well established that acidification of nitrite leads to liberation of nitric oxide (Furchgott, 1988) , it is unclear why acidification should have the additional effect of catalysing the reaction of nitric oxide with Lcysteine. What is clear, however, is that as the chemical reaction between nitric oxide and L-cysteine proceeds so inefficiently at neutral pH, it is unlikely that sufficient Snitrosocysteine is produced under normal physiological conditions to account for the activity of the NANC neurotransmitter.
Further evidence against S-nitrosocysteine or Snitrosoglutathione acting as the NANC transmitter in the BRP was obtained using the superoxide anion-generating agents, pyrogallol and hydroquinone. These agents have previously been reported to destroy the activity of authentic nitric oxide but do not affect neurogenic relaxation in the BRP or mouse anococcygeus (Gillespie & Sheng, 1990; Gibson et al., 1992) , suggesting that the NANC transmitter involved is a superoxide anion-insensitive, nitric oxidereleasing molecule. We found that pyrogallol and hydroquinone both destroyed the relaxant activity of Snitrosocysteine, S-nitrosoglutathione and nitric oxide when added to their respective solutions or to the BRP assay tissue, but as before, neither affected relaxation to NANC nerve stimulation. Furthermore, superoxide dismutase potentiated the relaxant actions of nitric oxide and the Snitrosothiols but had no effect on those to NANC nerve stimulation. Our findings confirm those of Gibson et al. (1992) who also found that hydroquinone inhibits the relaxant activity of S-nitrosocysteine, but not of NANC nerve stimulation in the mouse anococcygeus. In contrast to our findings, however, they reported that hydroquinone did not block the actions of S-nitrosoglutathione. Whether this disparity is due to differences in concentrations of drugs used or methods in preparing the nitrosothiol is unclear at present. We are in agreement, however, that the ability of free radical-generating drugs to destroy the activity of Snitrosocysteine precludes the involvement of this substance in NANC transmission in the BRP and anococcygeus muscles.
In conclusion, although the sulphydryl inactivating agents, diamide and N-ethylmaleimide, inhibit NANC relaxation in the BRP, this occurs through a non-selective action rather than from an inability to form an S-nitrosothiol. Nitric oxide can react in the presence of oxygen and at acid pH with sulphydryl compounds to produce S-nitrosothiols which are potent, long-lasting smooth muscle relaxants. The ability of superoxide anion-generating drugs to inhibit the relaxant actions of these S-nitrosothiols as well as of nitric oxide but not of the NANC nerves, suggests that these substances are not candidates for the inhibitory transmitter. The data suggest that the NANC neurotransmitter is more likely to be a superoxide anion-resistant, nitric oxide-releasing molecule. 
